Literature DB >> 27802075

Kinase Inactive Tyrosine Kinase (Tyk2) Supports Differentiation of Brown Fat Cells.

Vidisha Raje1, Marta Derecka1, Marc Cantwell1, Jeremy Meier1, Karol Szczepanek1,2, Jennifer D Sisler1, Birgit Strobl3, Ana Gamero4, Thurl E Harris5, Andrew C Larner1.   

Abstract

It has been known for decades that brown adipose tissue (BAT) plays a central role in maintaining body temperature in hibernating animals and human infants. Recently, it has become evident that there are also depots of brown fat in adult humans, and the mass of brown fat is inversely correlated with body weight. There are a variety of transcription factors implicated in the differentiation of classical Myf5+ brown preadipocytes, one of the most important of which is PRDM16. We have recently identified that in addition to PRDM16, the tyrosine kinase Tyk2 and the STAT3 transcription factor are required for the differentiation of Myf5 positive brown preadipocytes both in cell culture and in mice. Tyk2 is a member of the Jak family of tyrosine kinases, which are activated by exposure of cells to different cytokines and growth factors. In this study we report the surprising observation that a mutated form of Tyk2, which lacks tyrosine kinase activity (Tyk2KD) restores differentiation of brown preadipocytes in vitro as well as in Tyk2-/- mice. Furthermore, expression of the Tyk2KD transgene in brown fat reverses the obese phenotype of Tyk2-/- animals. Treatment of cells with Jak-selective inhibitors suggests that the mechanism by which Tyk2KD functions to restore BAT differentiation is by dimerizing with kinase active Jak1 or Jak2. These results indicate that there are redundant mechanisms by which members of the Jak family can contribute to differentiation of BAT.
Copyright © 2017 by the Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27802075      PMCID: PMC5412977          DOI: 10.1210/en.2015-2048

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.

Authors:  Zhi Li; Milica Gakovic; Josiane Ragimbeau; Maija-Leena Eloranta; Lars Rönnblom; Frédérique Michel; Sandra Pellegrini
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

Review 2.  Non-pharmacological and pharmacological strategies of brown adipose tissue recruitment in humans.

Authors:  Paul Lee; Jerry R Greenfield
Journal:  Mol Cell Endocrinol       Date:  2015-05-27       Impact factor: 4.102

3.  The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.

Authors:  Daniela Ungureanu; Jinhua Wu; Tuija Pekkala; Yashavanthi Niranjan; Clifford Young; Ole N Jensen; Chong-Feng Xu; Thomas A Neubert; Radek C Skoda; Stevan R Hubbard; Olli Silvennoinen
Journal:  Nat Struct Mol Biol       Date:  2011-08-14       Impact factor: 15.369

4.  Partial impairment of cytokine responses in Tyk2-deficient mice.

Authors:  M Karaghiosoff; H Neubauer; C Lassnig; P Kovarik; H Schindler; H Pircher; B McCoy; C Bogdan; T Decker; G Brem; K Pfeffer; M Müller
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

5.  Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity.

Authors:  Marta Derecka; Agnieszka Gornicka; Sergei B Koralov; Karol Szczepanek; Magdalena Morgan; Vidisha Raje; Jennifer Sisler; Qifang Zhang; Dennis Otero; Joanna Cichy; Klaus Rajewsky; Kazuya Shimoda; Valeria Poli; Birgit Strobl; Sandra Pellegrini; Thurl E Harris; Patrick Seale; Aaron P Russell; Andrew J McAinch; Paul E O'Brien; Susanna R Keller; Colleen M Croniger; Tomasz Kordula; Andrew C Larner
Journal:  Cell Metab       Date:  2012-12-05       Impact factor: 27.287

6.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 7.  The role of JAK-STAT signaling in adipose tissue function.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Biochim Biophys Acta       Date:  2013-06-02

8.  Activation of Stat3 signaling in AgRP neurons promotes locomotor activity.

Authors:  Andrea Mesaros; Sergei B Koralov; Eva Rother; F Thomas Wunderlich; Marianne B Ernst; Gregory S Barsh; Klaus Rajewsky; Jens C Brüning
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

9.  A smooth muscle-like origin for beige adipocytes.

Authors:  Jonathan Z Long; Katrin J Svensson; Linus Tsai; Xing Zeng; Hyun C Roh; Xingxing Kong; Rajesh R Rao; Jesse Lou; Isha Lokurkar; Wendy Baur; John J Castellot; Evan D Rosen; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2014-04-04       Impact factor: 27.287

10.  JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.

Authors:  Mark A Dawson; Andrew J Bannister; Berthold Göttgens; Samuel D Foster; Till Bartke; Anthony R Green; Tony Kouzarides
Journal:  Nature       Date:  2009-09-27       Impact factor: 49.962

View more
  4 in total

Review 1.  Brown and Beige Adipose Tissues in Health and Disease.

Authors:  Liangyou Rui
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

2.  STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis.

Authors:  Marc T Cantwell; Jared S Farrar; Joseph C Lownik; Jeremy A Meier; Moonjung Hyun; Vidisha Raje; Michael R Waters; Francesco S Celi; Daniel H Conrad; Thurl E Harris; Andrew C Larner
Journal:  Cytokine       Date:  2018-06-19       Impact factor: 3.861

Review 3.  TYK2: An Upstream Kinase of STATs in Cancer.

Authors:  Katharina Wöss; Natalija Simonović; Birgit Strobl; Sabine Macho-Maschler; Mathias Müller
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

4.  TYK2 licenses non-canonical inflammasome activation during endotoxemia.

Authors:  Andrea Poelzl; Caroline Lassnig; Simone Tangermann; Dominika Hromadová; Ursula Reichart; Riem Gawish; Kristina Mueller; Richard Moriggl; Andreas Linkermann; Martin Glösmann; Lukas Kenner; Mathias Mueller; Birgit Strobl
Journal:  Cell Death Differ       Date:  2020-09-14       Impact factor: 12.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.